Cell paper details how a high dose CRISPR therapy edited Duchenne muscle and killed one boy in 81 hours
Four boys with Duchenne muscular dystrophy received a single infusion of HuidaGene's HG302; two walked farther a year later, and the fourth died of an immune reaction within days.